Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Improving savings begins with fixing budgets that underperform. Rebalance, automate, and review goals to steadily grow your nest egg.
17,438 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Rumors swirl about Prince Andrew facing arrest in a public-office misconduct probe. This report examines his estimate...
As Advansix positions itself in a volatile chemical market, understanding advansix (asix) 2025 earnings becomes essen...
When a well-known fund exits a position, it invites scrutiny. This fund dumped million in Graphic Packaging as shares...
Ethereum tests $1,800 as Vitalik Buterin liquidates more than 10,700 ETH since early February. The move sparks renewe...
A broad market rally lifted major indexes on Feb. 24 as traders anticipated Nvidia’s earnings and awaited remarks fro...
A practical, investor-focused look at delcath (dcth) 2025 earnings prospects. We break down the catalysts, risks, and...
Bitcoin briefly peaked above $69k this week before pulling back toward $65k as equity markets turned lower and gold c...
River Road Asset Management just added a notable new position in AptarGroup, acquiring 917,670 shares valued at about...
What if you could cap downside risk while preserving upside potential? This deep dive shares how defined outcome inve...
A surprise $3 billion Fed liquidity operation comes as oil-driven market jitters push risk assets, including Bitcoin,...
Quantum computing is moving from theory to real-world profit paths. This guide highlights two stocks and a practical ...